Tue, Oct 21, 2014, 8:07 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Sarepta Therapeutics, Inc. Message Board

  • jonzkeleeyzfanclub jonzkeleeyzfanclub Nov 29, 2012 6:43 PM Flag

    Lilly's Cialis shows promise in muscular dystrophy, WSJ says

    ooopsssssssss

    Eli Lilly's (LLY) erectile dysfunction treatment Cialis has shown promise in treating Becker muscular dystrophy in a small study, The Wall Street Journal reported last night. If the promise suggested by the initial human study continues in further research, it may present a potential new approach for the more common form of the disease, Duchenne muscular dystrophy, or DMD, the report noted. The Fly notes that Sarepta (SRPT) is developing a treatment for DMD.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SRPT
22.49-0.34(-1.49%)Oct 21 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.